Aker BioMarine AS reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 88.6 million compared to USD 73.4 million a year ago. Net loss was USD 2.4 million compared to net income of USD 15 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to basic earnings per share from continuing operations of USD 0.17 a year ago. Diluted loss per share from continuing operations was USD 0.03 compared to diluted earnings per share from continuing operations of USD 0.17 a year ago.
For the six months, sales was USD 157.8 million compared to USD 130.3 million a year ago. Net loss was USD 20 million compared to net income of USD 5.3 million a year ago. Basic loss per share from continuing operations was USD 0.23 compared to basic earnings per share from continuing operations of USD 0.06 a year ago. Diluted loss per share from continuing operations was USD 0.23 compared to diluted earnings per share from continuing operations of USD 0.06 a year ago.